VPS25

VPS25 (EAP20) is a winged-helix subunit of the ESCRT-II complex that couples endosomal sorting of ubiquitinated transmembrane receptors to the downregulation of developmental signaling pathways (PMID:16256743, PMID:16256745, PMID:15579210). Structurally, each VPS25 monomer comprises two tandem winged-helix domains and assembles as two copies within ESCRT-II alongside single copies of Vps22 and Vps36, with no conformational change upon complex incorporation (PMID:15579210). VPS25 directly binds the ESCRT-III component CHMP6 through CHMP6's N-terminal basic region, acting as the acceptor that bridges ESCRT-II to ESCRT-III on endosomal membranes (PMID:15511219). Loss of VPS25 blocks endosomal sorting and causes accumulation of signaling receptors, leading to hyperactivation of Notch and Dpp signaling, non-autonomous JAK-STAT activation, ectopic organizer formation, and overproliferation that can progress to metastatic tumor-like overgrowths when apoptosis is suppressed (PMID:16256743, PMID:16256745, PMID:16611691). This receptor regulation is selective: hypomorphic Vps25 specifically perturbs FGFR trafficking and degradation to hyperactivate the FGF-SHH loop while leaving WNT, BMP, and SHH responses intact (PMID:25373905). Beyond canonical ESCRT function, VPS25 serves as the RNA-binding subunit of ESCRT-II, directly recognizing GA-rich polypurine motifs (PMID:29903915). VPS25 knockdown in human glioma cells arrests the cell cycle at G0/G1 and promotes apoptosis through modulation of p21, CDK2, and cyclin E and suppression of JAK-STAT signaling (PMID:34863175).

1. 2004 High

   Establishing the architecture of VPS25 was needed to understand how it functions within ESCRT-II; the structure revealed a tandem winged-helix fold and defined the two-copy stoichiometry of the complex.

   Evidence X-ray crystallography at 3.1 Å with comparison to the intact ESCRT-II complex

   PMID:15579210

   Open questions at the time

   • Does not address how VPS25 engages cargo or downstream ESCRT-III partners
   • No structure of the RNA-bound or CHMP6-bound state
2. 2005 High

   It was unclear how ESCRT-II connects to the membrane-remodeling ESCRT-III machinery; the discovery that VPS25/EAP20 directly binds CHMP6 defined the molecular bridge between the two complexes.

   Evidence Co-IP in HEK-293, in vitro pull-down with purified recombinant proteins, and co-localization in HeLa cells

   PMID:15511219

   Open questions at the time

   • Does not resolve the structural basis of the VPS25-CHMP6 interface
   • Functional consequence for cargo sorting inferred from overexpression phenotypes
3. 2005 High

   The physiological role of ESCRT-II in tissue signaling was unknown; Drosophila vps25 loss-of-function showed that VPS25 limits Notch and Dpp signaling by sorting receptors into the degradative pathway, linking endosomal trafficking to growth control.

   Evidence Drosophila genetic mosaic analysis, endosomal receptor immunofluorescence, epistasis with Notch/JAK-STAT/apoptosis pathways

   PMID:16256743 PMID:16256745

   Open questions at the time

   • Whether receptor accumulation is a direct or indirect consequence of sorting block
   • Did not identify the specific receptor degradation step VPS25 controls
4. 2006 High

   How loss of VPS25 triggers non-autonomous overgrowth versus autonomous death was open; epistasis showed mutant cells activate JAK-STAT non-autonomously while undergoing Hid/JNK apoptosis under Hippo control.

   Evidence Drosophila genetic screen, mosaic analysis, and epistasis with hid, JNK, and hippo mutants

   PMID:16611691

   Open questions at the time

   • Molecular link between receptor accumulation and Hippo pathway activation not defined
   • Conservation of the apoptotic/proliferative balance in mammals not tested
5. 2006 Low

   Sequence determinants of VPS25 assembly were uncharacterized; comparative analysis proposed N-terminal PPXY motifs and Arg-83 in dimerization and Vps22/Vps36 contacts and a conserved C-terminal lysine as a possible ubiquitination site.

   Evidence Comparative sequence analysis of 119 orthologs cross-referenced to yeast structural data

   PMID:16889659

   Open questions at the time

   • Computational inference without direct experimental validation in this study
   • Predicted ubiquitination of the C-terminal lysine untested
   • PPXY motif function not confirmed by mutagenesis here
6. 2011 Medium

   Whether VPS25 could be co-opted to redirect ESCRT handoff was unknown; Spry2 was shown to bind EAP20 and disrupt the ESCRT-I-to-ESCRT-II handoff, modulating HIV-1 Gag VLP release.

   Evidence Co-IP, VLP release assays in COS-1 cells, Spry2 fragment co-expression, and Spry2 siRNA knockdown

   PMID:21543492

   Open questions at the time

   • Single lab with two complementary methods, no reciprocal structural validation
   • Physiological relevance of Spry2-EAP20 binding outside viral budding unclear
7. 2014 High

   Whether ESCRT-II receptor regulation is general or selective was unresolved; mouse Vps25 hypomorphs showed it preferentially controls FGFR trafficking and the FGF-SHH loop without affecting WNT, BMP, or SHH responses.

   Evidence ENU mutagenesis, Vps25-null mice, MEF FGFR trafficking assays, and pathway-specific signaling readouts

   PMID:25373905

   Open questions at the time

   • Mechanistic basis of receptor selectivity not defined
   • Whether selectivity reflects cargo recognition or differential degradation kinetics unknown
8. 2018 High

   A non-trafficking activity of ESCRT-II was undefined; reconstitution and CLIP-Seq established VPS25 as the RNA-binding subunit recognizing GA-rich polypurine motifs.

   Evidence UV cross-linking, CLIP-Seq motif identification, and in vitro RNA-binding reconstitution with purified components

   PMID:29903915

   Open questions at the time

   • Functional consequence of VPS25-RNA binding for the bound mRNAs not established
   • Relationship between RNA binding and endosomal sorting unknown
9. 2020 Medium

   Whether ESCRT-II is required for all enveloped-virus egress was tested; VPS25 knockdown did not alter HSV-1 yields, showing it is dispensable for HSV-1 replication.

   Evidence siRNA knockdown confirmed by Western blot and quantitative ESCRT-II functional assay, single-step viral replication assay

   PMID:31748394

   Open questions at the time

   • Negative result does not exclude redundancy with other ESCRT routes
   • Does not address other herpesviruses or cargo classes
10. 2021 Medium

    The relevance of VPS25 to human cancer cell proliferation was untested; knockdown in glioma cells arrested cells at G0/G1 and induced apoptosis via p21/CDK2/cyclin E and JAK-STAT modulation.

    Evidence siRNA/shRNA knockdown, flow cytometry cell cycle analysis, western blotting, and transcriptome sequencing

    PMID:34863175

    Open questions at the time

    • Whether cell cycle effects are downstream of endosomal sorting or RNA binding not resolved
    • Single cancer cell type, single study
11. 2026 Medium

    Whether VPS25 supports specific viral life cycles was further probed; EAP20 was shown to aid PRRSV endosomal entry and to interact with Nsp2/Nsp5/Nsp9 to build ER-derived double-membrane replication vesicles.

    Evidence siRNA knockdown, co-IP, confocal microscopy, and viral entry/replication assays

    PMID:41805194

    Open questions at the time

    • Direct vs indirect nature of Nsp interactions not structurally validated
    • Single lab, single study

• How VPS25 achieves receptor selectivity and how its RNA-binding activity integrates with its canonical ESCRT sorting role remain unresolved.
• No structural model of cargo selectivity
• Functional output of GA-rich mRNA binding undefined
• Link between ESCRT sorting and cell cycle control in human cells unestablished